查看購物車
  • Simplified Chinese
  • English
  • Japanese
體重管理補充劑的全球市場-2022-2029
市場調查報告書
商品編碼
1146424

體重管理補充劑的全球市場-2022-2029

Global Weight Management Supplements Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期間（2022-2029 年），體重管理補充劑的市場規模預計將以 12.4% 的複合年增長率增長。

旨在添加或補充飲食的維生素、礦物質、草藥產品或其他製劑與用於增加或減輕體重的傳統食物不同，都被認為是體重控制補充劑。是已知的。

市場動態

越來越多的肥胖患者和對生活方式相關疾病的認識不斷提高，推動了對體重管理補充劑的需求。補品具有不吃不喝、不運動也能保持體力、提高免疫力、增肌的作用。

不斷上升的肥胖病例和對生活方式疾病的認識不斷提高正在推動全球市場的增長。

全球肥胖和超重病例數量的增加以及對生活方式相關疾病的認識不斷提高，正在推動全球體重管理補充劑市場的增長。例如，在世界肥胖日，世界衛生組織表示，全球有超過 10 億人肥胖，其中成年人約 6.5 億，青少年約 3.4 億，兒童約 3900 萬。肥胖繼續增加。世衛組織預測，到 2025 年，將有超過 1.67 億成人和兒童因肥胖或超重而變得不健康。此外，肥胖會增加患心血管疾病、脂肪肝和糖尿病等非傳染性疾病和代謝疾病的風險。因此，非傳染性疾病導致的死亡發病率不斷上升，正在提高公眾對肥胖對健康影響的認識，這反過來又推動了全球體重管理補充劑的整體增長。

缺乏對某些成分的補充劑功效和副作用的保證正在阻礙全球體重管理補充劑市場的增長。

然而，缺乏對補充劑功效和某些成分副作用的保證阻礙了全球體重管理補充劑市場的增長。例如，美國政府問責局的聲明得出的結論是，人們對減肥補充劑是否有影響知之甚少，而一些補充劑與潛在的身體傷害有關。我在這裡。例如，鈣是減肥補充劑中的常見成分，但幾項大型臨床試驗顯示對減肥沒有明顯效果。儘管如此，在這些試驗中報告了嚴重的副作用。

COVID-19 的影響

COVID-19 的爆發對全球體重管理補充劑市場產生了積極影響，因為研究表明肥胖是 COVID-19 住院和死亡的新威脅。例如，世界衛生組織指出 60% 的歐洲人口超重或肥胖，這表明肥胖流行病，尤其是 COVID-19 的影響，因為它造成了增加發病率和死亡率的雙重流行病。隨著世界人口對體重管理的關注，人們正在選擇體重管理補充劑，因為在當今忙碌的生活中很難保持適當的飲食和鍛煉 2022 年報告發布了該書。

細分分析

在預測期內（2022-2029 年），預計女性將在體重管理補充劑市場中佔據更大份額。

由於性別是肥胖的重要風險因素，預計女性最終用戶將在預測期間（2022-2029 年）佔據大部分市場份額。女性肥胖的可能性是肥胖男性的兩倍，因此與肥胖男性相比，女性患多種與肥胖相關的慢性身體和心理疾病的風險更高，死亡風險是肥胖男性的兩倍。已經提出了幾個風險因素來解釋肥胖表型與性別之間的關係。這些差異對個人的醫療、社會心理和經濟影響具有深遠的影響。

例如，世界肥胖聯盟發布的《2022 年全球肥胖圖譜》預測，到 2030 年，將有 10 億人肥胖，其中包括五分之一的女性和七分之一的男性。這代表著超重女性人口的快速增長，從而主導體重管理補充劑市場。

區域分析

預計北美將主導體重管理補充劑的全球市場。

北美主導著全球體重管理補充劑市場。預計在預測期內（2022-2029 年）將占主導地位，因為通過各種市場策略在體重管理補充劑市場佔有很大份額的大多數主要市場參與者都位於美國。例如，康寶萊營養、雅培營養、阿特金斯營養、Nutrisystem、安利等。此外，該地區不斷增長的肥胖人口保證了體重管理市場的主導地位。例如，根據全球肥胖觀察站的數據，36.47% 的成年男性和 38.16% 的成年女性超重。由於快餐消費占美國人平均飲食的 11% 左右，美國人的肥胖率正在上升。肥胖症每年的成本估計為 1490 億美元，其中大約一半由醫療保險和醫療補助計劃承保。因此，從上述數據推斷，在預測期內，北美將主導全球體重管理補充劑市場。

競爭格局

Abbott Laboratories 是一家美國醫療器械和醫療保健公司，成立於 1888 年，總部位於美國伊利諾伊州的 Abbott Park。 Abbott Laboratories 生產和交易醫療器械、診斷產品、品牌仿製藥和營養產品。 Abbott Laboratories 擁有 ZonePerfect、PediaSure、Similac、Pedialyte、Juven 和 Nepro 等營養產品品牌。

產品組合

Abbott Laboratories 的體重管理補充劑產品組合包括 ENSURE。確保品牌產品為活躍的成年人提供營養來源，幫助他們專注於特定的營養目標。

全球體重管理補充報告將提供對 40 多個 市場數據表、45 多個數字和 200 頁（大約）的訪問。

內容

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 肥胖病例不斷增加
      • 提高認識
    • 限制因素
      • 缺乏有效性保證
      • 副作用
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按形狀

  • 軟凝膠
  • 藥片
  • 粉末
  • 液體

第 8 章最終用戶

  • 成年男性
  • 成年女性
  • 老年人
  • 兒童

第 9 章分銷渠道

  • 藥店
  • 保健美容店
  • 大賣場/超市
  • 在線銷售
  • 其他銷售渠道

第 10 章按成分分類

  • 維生素和礦物質
  • 氨基酸
  • 植物補充劑
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 13 章公司簡介

  • 雅培營養
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Glanbia Nutritionals PLC
  • Herbalife
  • Lovate Health Sciences
  • Oriflame
  • Atkins Nutritional
  • Nestle SA
  • Nutrisystem
  • Bioalpha Holdings Berhad
  • Amway
  • White Heron Pharmaceutical

第14章 DataM

簡介目錄
Product Code: DMPH252

Market Overview

Weight Management Supplements Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 12.4% during the forecast period (2022-2029).

Any vitamin, mineral, herbal product, or other formulation intended to add to or supplement the diet and is different from conventional food ingested to gain or lose weight is known as a weight management supplement.

Market Dynamics

Growth in obesity cases and increasing awareness of lifestyle diseases drive the demand for weight management supplements. They help maintain fitness without needing a dietary meal or exercise, improve their immune system and build muscle mass.

The growing obesity cases and increasing awareness of lifestyle diseases drive global market growth.

The growing cases of obesity and overweight globally and the increasing awareness about lifestyle diseases are boosting the global weight management supplement market growth. For instance, on world obesity day, WHO presented data that indicated over 1 billion people worldwide are obese, of which around 650 million are adults, nearly 340 million are adolescents, and approximately 39 million are children. The cases of obesity are still increasing. The WHO predicts that over 167 million adults and children will become unhealthy due to obesity or overweight by 2025. Furthermore, with obesity, there is a high risk for non-communicable diseases and metabolic diseases such as cardiovascular diseases, fatty liver diseases, diabetes, Etc. Thus, the increasing incidences of non-communicable diseases caused deaths is increasing awareness in the population about the impacts of obesity on health which in turn is fueling the overall growth of the global weight management supplement.

The lack of assurance about the effectiveness of the supplements and the side effects of a few ingredients is hampering the global weight management supplement market growth.

However, the lack of assurance about the effectiveness of the supplements and the side effects of a few ingredients is hampering the global weight management supplement market growth. For instance, the declaration from the U.S. Government Accountability Office concluded that remarkably little is apprehended about whether weight loss supplements are influential, while some supplements have been associated with the potential for physical harm; for example, Calcium is one of the common ingredients from weight management supplement which has not shown any evident effect on weight loss in several large clinical trials. Still, there have been reports of severe adverse effects in these trials.

COVID-19 Impact.

The COVID-19 outburst has positively impacted the global weight management supplement market, as studies indicated that obesity is a novel threat to hospitalization and death due to COVID-19. For instance, WHO released a 2022 report on the state of the obesity pandemic in Europe, showing that 60% of the population in Europe is either overweight or obese and insinuating the effects of the obesity pandemic, particularly as it interacts with the COVID pandemic to creating a twin pandemic boosting the morbidity and mortality, which has increased the world population focus towards weight management, and since maintaining proper diet and exercise in today's busy life is difficult people are opting for weight management supplements.

Segment Analysis

Female are expected to have a greater grasp of the weight management supplements market during the forecast period (2022-2029).

Female end users are expected to hold most of the market share throughout the forecast period (2022-2029) as gender is an important risk factor for the development of obesity. The female gender is at twice the danger of being obese; thereby are at higher risk of acquiring multiple chronic obesity-related physical and psychological conditions and have a double mortality risk compared to obese men. Some risk factors have been represented to describe the gender relation with an obese phenotype. These disparities have far-reaching implications on an individual's medical, psychosocial, and economic impact.

For instance, the World Obesity Atlas 2022, issued by the World Obesity Federation, anticipates that one billion people globally, including 1 out of 5 women and 1 out of 7 men, will be obese by 2030, indicating that the overweight female population is increasing rapidly, thus, dominating the weight management supplement market.

Geographical Analysis

North America is expected to dominate the global weight management supplements market.

North America commands the global weight management supplement market. It is anticipated to dominate during the forecast period (2022-2029) as most of the key market players holding a large share of the weight management supplement market through various market strategies are U.S. based. For instance, Herbalife Nutrition, Abbott Nutrition, Atkins Nutritional, Nutrisystem and Amway. Furthermore, the growing obese population in this region ensures its dominance over the weight management market. For instance, as per the Global Obesity Observatory, 36.47% of adult males and 38.16% of adult females are overweight. The increasing obesity in the American population is due to fast-food consumption, which makes up about 11% of the average American diet. Obesity is estimated to increase healthcare spending by $149 billion annually, about half of which is paid for by Medicare and Medicaid. Therefore, with the above-mentioned data, it is estimated that North America will dominate the global weight management supplement market during the forecast period.

Competitive Landscape

The key players operating in the global weight management supplements market are Abbott Nutrition, Glanbia Nutritionals PLC, Herbalife, Lovato Health Sciences, Oriflame, Atkins Nutritional, Nestle SA, Nutrisystem, Bioalpha Holdings Berhad, Amway, and White Heron Pharmaceutical. The key players are embracing various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the weight management supplements market globally. For instance, in July 2022, Herbalife Nutrition launched Fat Release to support its consumers' healthy and active lifestyles. This product enables trimming the fat from food to uphold consumers on track with their health objectives.

Abbott Laboratories.

Overview:

Abbott Laboratories is an American global medical device and healthcare company founded in 1888 with headquarters in Abbott Park, Illinois, United States. Abbott Laboratories manufacture and trades medical devices, diagnostics, branded generic medicines and nutritional products. Abbott Laboratories has nutrition product brands such as ZonePerfect, PediaSure, Similac, Pedialyte, Juven, Nepro, Etc.

Product Portfolio:

The product portfolio of Abbott Laboratories for weight management supplements has ENSURE: The Ensure brand products nourish active adults with a source of nutrition that can aid them in focusing on explicit nutritional goals.

The global weight management supplements report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Cases of Obesity
      • 4.1.1.2. Increasing Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Effectiveness Assurance
      • 4.1.2.2. Side Effects
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Soft Gel
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Pills
  • 7.4. Powder
  • 7.5. Liquid

8. By End Users

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 8.1.2. Market Attractiveness Index, By End Users
  • 8.2. Adult Men
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Adult Women
  • 8.4. Senior Citizens
  • 8.5. Children

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Drug Store
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Health & Beauty Store
  • 9.4. Hypermarket/Supermarket
  • 9.5. Online Sales
  • 9.6. Other Sales Channel

10. By Ingredients

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredients
    • 10.1.2. Market Attractiveness Index, By Ingredients
  • 10.2. Vitamins & Minerals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Amino Acids
  • 10.4. Botanical Supplements
  • 10.5. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Abbott Nutrition
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Glanbia Nutritionals PLC
  • 13.3. Herbalife
  • 13.4. Lovate Health Sciences
  • 13.5. Oriflame
  • 13.6. Atkins Nutritional
  • 13.7. Nestle SA
  • 13.8. Nutrisystem
  • 13.9. Bioalpha Holdings Berhad
  • 13.10. Amway
  • 13.11. White Heron Pharmaceutical

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us